Article
US Representatives Push to Grant (Re)Insurers SRT Recognition in the US
Reporting: Vincent Nadeau
A bipartisan pair of senior House Financial Services Committee members, Reps. Andy Barr, R-Calif., and Jim Himes, D-Conn., have written jointly to the Federal Reserve, the Office of the Comptroller of the Currency and the Federal Deposit Insurance Corp., urging an update to the U.S. Basel III capital framework.
The letter has direct relevance to the significant risk transfer, or SRT, market, where insurance and reinsurance companies are increasingly active as protection providers in Europe and where U.S. recognition could unlock a significant new pool of capacity.
The June 12 letter, seen by Octus, asks regulators to formally recognize regulated insurance and reinsurance companies as “eligible guarantors” under the capital rules, on equal footing with other prudentially regulated financial companies such as commercial banks.
The letter quotes Federal Reserve Vice Chair for Supervision Michelle Bowman’s remarks in 2023, stating that capital rules should give greater recognition to transfers of risk that achieve the same economic outcome as permitted risk transfer under the rules and adding that elevating form over substance is contrary to the goal of improving risk capture.
The congressmen call the regulators’ own stated principles back into action, noting that while the international Basel Capital Accord explicitly affirms that prudentially regulated insurance companies can serve as eligible credit protection providers, U.S. regulations have lagged, leaving domestic banks, in the letter’s words, at “a competitive disadvantage to banks from jurisdictions that have implemented this provision of the Accord.”
Today, most insurers fail to qualify as eligible guarantors on two counts. The eligible guarantor definition, set out in U.S. Basel III capital rules, does not categorically recognize insurance companies at all, unlike commercial banks and other regulated financial institutions. The alternative route open to corporate entities requires the protection provider to have issued investment-grade debt securities in its own name, a bar that most insurance subsidiaries cannot clear since they typically issue no debt independently of their wider group.
The letter itself notes that the agencies’ current Basel III and Standardised Approach for Counterparty Credit Risk proposals are explicitly seeking comment on whether the eligible guarantor definition warrants revision, underscoring the timeliness of the request.
This publication has been prepared by Octus Intelligence, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2026 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.